Evolutionarily conserved mechanisms of lifespan regulation
Evolutionarily conserved mechanisms of lifespan regulation
批准号:
8255500
负责人:
Sean P CURRAN
金额:
$24.41万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-15 至 2014-03-31
关键词:
AdultAgeAgingAging-Related ProcessBioinformaticsBiologicalBiological FactorsCaenorhabditis elegansCellsCellular biologyCytoplasmic GranulesDataDemographyDevelopmentDiapauseDiseaseDouble-Stranded RNADrosophila melanogasterEssential GenesGene ExpressionGene ProteinsGene SilencingGene TargetingGenesGeneticGenetic ScreeningGenomicsGoalsGrowthHomologous GeneHouse miceHumanImmunofluorescence ImmunologicIncidenceInformaticsInsulin Signaling PathwayKnock-outLarvaLibrariesLifeLongevityMammalsMapsMass Spectrum AnalysisMeasuresMetabolicMetabolismMicroarray AnalysisMitochondriaMolecularMolecular ChaperonesMolecular ProfilingMonitorMusMutagenesisNeuronsNucleotidesOrthologous GenePathway interactionsPatternPhenotypePilot ProjectsProteinsPublic HealthRNA InterferenceRegulationRegulator GenesReporterReproductionResistanceReverse Transcriptase Polymerase Chain ReactionSpecificityStressTamoxifenTestingTissuesTranscriptTransgenesTranslation InitiationYeastscell typeflyinsightinsulin signalingmanmutantneuronal cell bodynormal agingnovelpromoterrecombinaseresponsesuccess
中文摘要
尽管不同物种的最长寿命存在巨大差异,
控制寿命的机制是进化保守的;这项建议的目的是
识别和表征寿命延长的新机制,
进化保守这个项目的长期目标是确定
调节哺乳动物衰老过程的机制。第一个具体目标
研究了在RNAi筛选中鉴定的四个基因,以增加寿命。这四
除了增加成年人的寿命外,发育后的基因也会错误调节
生殖系/索马细胞类型特异性。这种表型虽然以前未被发现,
与已知的寿命调节器共享,并可能有助于增加
寿命和增强的抗压力能力。具体目标2利用经典的遗传
筛选以识别影响C寿命的三种途径中的新调节因子。优雅
一项初步研究已经确定了22种基因突变体,这些突变体调节蠕虫对三种
不同的途径,当功能减少时,平均成年寿命会增加。尽管
这些细胞通路的多样性,这些突变体的子集调节所有三个
机制,并可能代表寿命的主调节器。映射和
对这些gehelic突变体的表征将鉴定新的C. elegans
中心blog最后,先前在发育后RNAi中鉴定了64个基因,
筛选C.优雅超过90%的基因是
具体目标3将表征这些同源物的直系同源物,
果蝇和小鼠的基因,这可能揭示了寿命延长的保守机制。
我们将测试哺乳动物直系同源基因拯救功能之神的能力
蠕虫的表型。在蠕虫中使用GFP报告基因,沿着生物信息学和
小鼠直系同源物的RT-PCR表达分析,我们将比较
这些新的寿命调节剂起作用。根据这些标准,
保存的长寿调节剂和测试后发育的候选人
和小鼠中的靶向时间/组织特异性破坏。
英文摘要
Despite the vast differences in maximal lifespan across species some of the
mechanisms that control lifespan are evolutionary conserved; The aim of this proposal is
to identify and characterize novel mechanisms of lifespan extension that display
evolutionary conservation. The long-term goal of this project is acertain the genetic
mechanisms in place that regulate the aging process in mammals. The first specific aim
examines four genes identified in a RNAi screten for increased lifespan. These four
genes aside from increasing adult lifespan postdevelopmentally also misregulate the
germline/soma cell type specificity. This phenotype although previously undeseribed is
shared with known regulators of lifespan and may contribute to both the increased
lifespan and enhanced resistance to stress. Specific aim 2 utilizes a classical genetic
screen to identify new regulators in three pathways that influence lifespan in C. elegans.
A pilot study has identified 22 genetic mutants that regulate the worms response to three
distinct pathways which when reduced in function increase mean adult lifespan. Despite
the diversity in these cellular pathways a subset of these mutants regulate all three
mechanisms, and may represent master regulators of lifespan. Mapping and
characterization of these gehelic mutants will identify novel regulators of C. elegans
longevity. Finally, 64 genis were previously identified in a post-developmentar RNAi
screen for increased lifespan in C. elegans. More than 90% of these genes are
conserved from yeast to man. Specific aim 3 will characterize the orthologs of these
genes in fly and mouse, v/hich may reveal conserved mechanisms of lifespan extension.
We will test the ability of the mammalian orthologs to rescue the joss of function
phenotype in the worm. Using GFP reporters in the worm along with bioinformatic and
RT-PCR expression analysis of the mouse orthologs we wiN compare the tissues where
these novel lifespan regulators function. Using these criteria we will pick our best
candidates for conserved longevity regulators and test post-developmental khoekdown
in the fly and targeted temporal/tissue specific disruptions in the mouse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The University of Southern California and Buck Institute Nathan Shock Center
-
批准号:10407740
-
项目类别:
-
资助金额:$27.35万
-
财政年份:2020
-
负责人:Sean P CURRAN
-
依托单位:
The University of Southern California and Buck Institute Nathan Shock Center
-
批准号:10424589
-
项目类别:
-
资助金额:$92.33万
-
财政年份:2020
-
负责人:Sean P CURRAN
-
依托单位:
The University of Southern California and Buck Institute Nathan Shock Center
-
批准号:10649615
-
项目类别:
-
资助金额:$92.33万
-
财政年份:2020
-
负责人:Sean P CURRAN
-
依托单位:
The University of Southern California and Buck Institute Nathan Shock Center
-
批准号:10044920
-
项目类别:
-
资助金额:$92.33万
-
财政年份:2020
-
负责人:Sean P CURRAN
-
依托单位:
The University of Southern California and Buck Institute Nathan Shock Center
-
批准号:10261426
-
项目类别:
-
资助金额:$92.33万
-
财政年份:2020
-
负责人:Sean P CURRAN
-
依托单位:
Convergent approaches to lifespan health
-
批准号:9922196
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2019
-
负责人:Sean P CURRAN
-
依托单位:
Age-dependent SKN-1/NRF cytoprotection at the cost of metabolic homeostasis
-
批准号:10288687
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2019
-
负责人:Sean P CURRAN
-
依托单位:
Convergent approaches to lifespan health
-
批准号:10348149
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2019
-
负责人:Sean P CURRAN
-
依托单位:
Convergent approaches to lifespan health
-
批准号:10549832
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2019
-
负责人:Sean P CURRAN
-
依托单位:
Age-dependent SKN-1/NRF cytoprotection at the cost of metabolic homeostasis
-
批准号:10436150
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2019
-
负责人:Sean P CURRAN
-
依托单位:
Age-dependent SKN-1/NRF cytoprotection at the cost of metabolic homeostasis
-
批准号:10611507
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2019
-
负责人:Sean P CURRAN
-
依托单位:
USC-Buck Geroscience Training in the Biology of Aging
-
批准号:10659256
-
项目类别:
-
资助金额:$66.49万
-
财政年份:2016
-
负责人:Sean P CURRAN
-
依托单位:
USC-Buck Geroscience Training in the Biology of Aging
-
批准号:10393601
-
项目类别:
-
资助金额:$65.11万
-
财政年份:2016
-
负责人:Sean P CURRAN
-
依托单位:
USC-Buck Geroscience Training in the Biology of Aging
-
批准号:10172569
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2016
-
负责人:Sean P CURRAN
-
依托单位:
Novel roles for Maf1 as a central regulator of lipid homeostasis
-
批准号:8767350
-
项目类别:
-
资助金额:$31.27万
-
财政年份:2014
-
负责人:Sean P CURRAN
-
依托单位:
Novel roles for Maf1 as a central regulator of lipid homeostasis
-
批准号:8917059
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2014
-
负责人:Sean P CURRAN
-
依托单位:
Novel roles for Maf1 as a central regulator of lipid homeostasis
-
批准号:9134803
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2014
-
负责人:Sean P CURRAN
-
依托单位:
Evolutionarily conserved mechanisms of lifespan regulation
-
批准号:8429469
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2011
-
负责人:Sean P CURRAN
-
依托单位:
Evolutionarily conserved mechanisms of lifespan regulation
-
批准号:8183447
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Sean P CURRAN
-
依托单位:
Evolutionarily conserved mechanisms of lifespan regulation
-
批准号:8467853
-
项目类别:
-
资助金额:$2.65万
-
财政年份:2011
-
负责人:Sean P CURRAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: